startups technology enabled weight loss services glp-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo The Next Frontier in Healthcare

A 2024 meta-analysis found GLP-1 receptor agonists helped lower BMI, waist circumference, triglycerides, and total testosterone in women with PCOS living with obesity

Important context: this wasn't a targeted investigation of MEDVi alone

GLP-1s are still relatively new in the way theyre being used now, and we simply dont have enough data to understand their full impact over time especially in younger populations or those using them off-label

relevance to humans is currently unknown, and individuals with MTC or MEN2 history are excluded from trials

Youre like, OK, this isnt livable for me,' she explained

Front Surg